Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Proteogenomics: emergence and promise.

Faulkner S, Dun MD, Hondermarck H.

Cell Mol Life Sci. 2015 Jan 22. [Epub ahead of print]

PMID:
25609363
[PubMed - as supplied by publisher]
2.

NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Bradshaw RA, Pundavela J, Biarc J, Chalkley RJ, Burlingame AL, Hondermarck H.

Adv Biol Regul. 2014 Nov 20. pii: S2212-4926(14)00062-1. doi: 10.1016/j.jbior.2014.11.003. [Epub ahead of print]

PMID:
25491371
[PubMed - as supplied by publisher]
3.

ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer.

Pundavela J, Demont Y, Jobling P, Lincz LF, Roselli S, Thorne RF, Bond D, Bradshaw RA, Walker MM, Hondermarck H.

Am J Pathol. 2014 Dec;184(12):3156-62. doi: 10.1016/j.ajpath.2014.08.009. Epub 2014 Oct 5.

PMID:
25285721
[PubMed - in process]
4.

Antiproliferative and apoptotic effects of the oxidative dimerization product of methyl caffeate on human breast cancer cells.

Bailly F, Toillon RA, Tomavo O, Jouy N, Hondermarck H, Cotelle P.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):574-8. doi: 10.1016/j.bmcl.2012.11.009. Epub 2012 Nov 22.

PMID:
23228470
[PubMed - indexed for MEDLINE]
5.

Neurotrophins and their receptors in breast cancer.

Hondermarck H.

Cytokine Growth Factor Rev. 2012 Dec;23(6):357-65. doi: 10.1016/j.cytogfr.2012.06.004. Epub 2012 Jun 30. Review.

PMID:
22749855
[PubMed - indexed for MEDLINE]
6.

Proteome changes induced by overexpression of the p75 neurotrophin receptor (p75NTR) in breast cancer cells.

Wilmet JP, Tastet C, Desruelles E, Ziental-Gelus N, Blanckaert V, Hondermarck H, Le Bourhis X.

Int J Dev Biol. 2011;55(7-9):801-9. doi: 10.1387/ijdb.113345jw.

PMID:
22161836
[PubMed - indexed for MEDLINE]
Free Article
7.

Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.

Demont Y, Corbet C, Page A, Ataman-Önal Y, Choquet-Kastylevsky G, Fliniaux I, Le Bourhis X, Toillon RA, Bradshaw RA, Hondermarck H.

J Biol Chem. 2012 Jan 13;287(3):1923-31. doi: 10.1074/jbc.M110.211714. Epub 2011 Nov 29.

PMID:
22128158
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.

Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H.

Clin Cancer Res. 2011 Apr 1;17(7):1741-52. doi: 10.1158/1078-0432.CCR-10-1890. Epub 2011 Feb 24.

PMID:
21350004
[PubMed - indexed for MEDLINE]
Free Article
9.

Ku86 is important for TrkA overexpression-induced breast cancer cell invasion.

Lagadec C, Romon R, Tastet C, Meignan S, Com E, Page A, Bidaux G, Hondermarck H, Le Bourhis X.

Proteomics Clin Appl. 2010 Jul;4(6-7):580-90. doi: 10.1002/prca.200900148. Epub 2010 Mar 26.

PMID:
21137076
[PubMed - indexed for MEDLINE]
10.

Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1).

Verbeke S, Meignan S, Lagadec C, Germain E, Hondermarck H, Adriaenssens E, Le Bourhis X.

Cell Signal. 2010 Dec;22(12):1864-73. doi: 10.1016/j.cellsig.2010.07.014. Epub 2010 Jul 24.

PMID:
20667470
[PubMed - indexed for MEDLINE]
11.

Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways.

Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H, Le Bourhis X.

Mol Cancer. 2010 Jun 22;9:157. doi: 10.1186/1476-4598-9-157.

PMID:
20569463
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications.

Le Bourhis X, Romon R, Hondermarck H.

Breast Cancer Res Treat. 2010 Feb;120(1):17-24. doi: 10.1007/s10549-009-0686-5. Epub 2009 Dec 24. Review.

PMID:
20033768
[PubMed - indexed for MEDLINE]
13.

Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.

Collins BC, Lau TY, O'Connor DP, Hondermarck H.

EMBO Rep. 2009 Nov;10(11):1202-5. doi: 10.1038/embor.2009.222. Epub 2009 Oct 2. No abstract available.

PMID:
19798100
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

TrkA overexpression enhances growth and metastasis of breast cancer cells.

Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H, Le Bourhis X.

Oncogene. 2009 May 7;28(18):1960-70. doi: 10.1038/onc.2009.61. Epub 2009 Mar 30.

PMID:
19330021
[PubMed - indexed for MEDLINE]
15.

Identification of new p53 acetylation sites in COS-1 cells.

Joubel A, Chalkley RJ, Medzihradszky KF, Hondermarck H, Burlingame AL.

Mol Cell Proteomics. 2009 Jun;8(6):1167-73. doi: 10.1074/mcp.M800487-MCP200. Epub 2009 Jan 19.

PMID:
19155208
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The proteome of the human breast cancer cell line MDA-MB-231: Analysis by LTQ-Orbitrap mass spectrometry.

Strande V, Canelle L, Tastet C, Burlet-Schiltz O, Monsarrat B, Hondermarck H.

Proteomics Clin Appl. 2009 Jan;3(1):41-50. doi: 10.1002/prca.200800083. Epub 2008 Dec 9.

PMID:
21136935
[PubMed]
17.

A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression.

Berteaux N, Aptel N, Cathala G, Genton C, Coll J, Daccache A, Spruyt N, Hondermarck H, Dugimont T, Curgy JJ, Forné T, Adriaenssens E.

Mol Cell Biol. 2008 Nov;28(22):6731-45. doi: 10.1128/MCB.02103-07. Epub 2008 Sep 15.

PMID:
18794369
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nerve growth factor: the dark side of the icon.

Hondermarck H.

Am J Pathol. 2008 Apr;172(4):865-7. doi: 10.2353/ajpath.2008.080008. Epub 2008 Mar 18. No abstract available.

PMID:
18349120
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Proteomics of breast cancer: the quest for markers and therapeutic targets.

Hondermarck H, Tastet C, El Yazidi-Belkoura I, Toillon RA, Le Bourhis X.

J Proteome Res. 2008 Apr;7(4):1403-11. doi: 10.1021/pr700870c. Epub 2008 Feb 27. Review.

PMID:
18311906
[PubMed - indexed for MEDLINE]
20.

Nerve growth factor is a potential therapeutic target in breast cancer.

Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H.

Cancer Res. 2008 Jan 15;68(2):346-51. doi: 10.1158/0008-5472.CAN-07-1183.

PMID:
18199526
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk